The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Infectious Diseases Therapeutics Market Research Report 2025
Synopsis
Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.
The global Veterinary Infectious Diseases Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Infectious Diseases Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Infectious Diseases Therapeutics.
Report Scope
The Veterinary Infectious Diseases Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Infectious Diseases Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Infectious Diseases Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac
Segment by Type
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics
Segment by Application
Swine
Chicken
Dog
Cat
Cow
Horse
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Infectious Diseases Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Infectious Diseases Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.
The global Veterinary Infectious Diseases Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Infectious Diseases Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Infectious Diseases Therapeutics.
Report Scope
The Veterinary Infectious Diseases Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Infectious Diseases Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Infectious Diseases Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac
Segment by Type
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics
Segment by Application
Swine
Chicken
Dog
Cat
Cow
Horse
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Infectious Diseases Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Infectious Diseases Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Veterinary Infectious Diseases Therapeutics Market Overview
1.1 Product Overview and Scope of Veterinary Infectious Diseases Therapeutics
1.2 Veterinary Infectious Diseases Therapeutics Segment by Type
1.2.1 Global Veterinary Infectious Diseases Therapeutics Market Value Comparison by Type (2024-2030)
1.2.2 Antibiotics
1.2.3 Antiviral
1.2.4 Antifungal
1.2.5 Amebicides
1.2.6 Anthelmintics
1.3 Veterinary Infectious Diseases Therapeutics Segment by Application
1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Value by Application: (2024-2030)
1.3.2 Swine
1.3.3 Chicken
1.3.4 Dog
1.3.5 Cat
1.3.6 Cow
1.3.7 Horse
1.3.8 Other
1.4 Global Veterinary Infectious Diseases Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Veterinary Infectious Diseases Therapeutics Revenue 2019-2030
1.4.2 Global Veterinary Infectious Diseases Therapeutics Sales 2019-2030
1.4.3 Global Veterinary Infectious Diseases Therapeutics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Infectious Diseases Therapeutics Market Competition by Manufacturers
2.1 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Infectious Diseases Therapeutics Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary Infectious Diseases Therapeutics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Infectious Diseases Therapeutics, Product Type & Application
2.7 Veterinary Infectious Diseases Therapeutics Market Competitive Situation and Trends
2.7.1 Veterinary Infectious Diseases Therapeutics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Infectious Diseases Therapeutics Players Market Share by Revenue
2.7.3 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Infectious Diseases Therapeutics Retrospective Market Scenario by Region
3.1 Global Veterinary Infectious Diseases Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Infectious Diseases Therapeutics Global Veterinary Infectious Diseases Therapeutics Sales by Region: 2019-2030
3.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Region: 2019-2024
3.2.2 Global Veterinary Infectious Diseases Therapeutics Sales by Region: 2025-2030
3.3 Global Veterinary Infectious Diseases Therapeutics Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2019-2030
3.3.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2019-2024
3.3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2025-2030
3.4 North America Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Country
3.4.1 North America Veterinary Infectious Diseases Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
3.4.3 North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Country
3.5.1 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
3.5.3 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2030)
4.1.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type (2019-2024)
4.1.2 Global Veterinary Infectious Diseases Therapeutics Sales by Type (2025-2030)
4.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2030)
4.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2019-2024)
4.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2025-2030)
4.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Infectious Diseases Therapeutics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2030)
5.1.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application (2019-2024)
5.1.2 Global Veterinary Infectious Diseases Therapeutics Sales by Application (2025-2030)
5.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2030)
5.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2019-2024)
5.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2025-2030)
5.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Infectious Diseases Therapeutics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Elanco Animal Health
6.1.1 Elanco Animal Health Corporation Information
6.1.2 Elanco Animal Health Description and Business Overview
6.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
6.1.5 Elanco Animal Health Recent Developments/Updates
6.2 Novartis Animal Health
6.2.1 Novartis Animal Health Corporation Information
6.2.2 Novartis Animal Health Description and Business Overview
6.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
6.2.5 Novartis Animal Health Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Veterinary Infectious Diseases Therapeutics Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer Animal Health
6.4.1 Pfizer Animal Health Corporation Information
6.4.2 Pfizer Animal Health Description and Business Overview
6.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
6.4.5 Pfizer Animal Health Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Boehringer Ingelheim Vetmedica
6.6.1 Boehringer Ingelheim Vetmedica Corporation Information
6.6.2 Boehringer Ingelheim Vetmedica Description and Business Overview
6.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Portfolio
6.6.5 Boehringer Ingelheim Vetmedica Recent Developments/Updates
6.7 Dechra Animal Health
6.6.1 Dechra Animal Health Corporation Information
6.6.2 Dechra Animal Health Description and Business Overview
6.6.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
6.7.5 Dechra Animal Health Recent Developments/Updates
6.8 Ceva Sante Animale
6.8.1 Ceva Sante Animale Corporation Information
6.8.2 Ceva Sante Animale Description and Business Overview
6.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Portfolio
6.8.5 Ceva Sante Animale Recent Developments/Updates
6.9 Elanco Animal Health
6.9.1 Elanco Animal Health Corporation Information
6.9.2 Elanco Animal Health Description and Business Overview
6.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolio
6.9.5 Elanco Animal Health Recent Developments/Updates
6.10 Virbac
6.10.1 Virbac Corporation Information
6.10.2 Virbac Description and Business Overview
6.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Virbac Veterinary Infectious Diseases Therapeutics Product Portfolio
6.10.5 Virbac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Infectious Diseases Therapeutics Industry Chain Analysis
7.2 Veterinary Infectious Diseases Therapeutics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Infectious Diseases Therapeutics Production Mode & Process
7.4 Veterinary Infectious Diseases Therapeutics Sales and Marketing
7.4.1 Veterinary Infectious Diseases Therapeutics Sales Channels
7.4.2 Veterinary Infectious Diseases Therapeutics Distributors
7.5 Veterinary Infectious Diseases Therapeutics Customers
8 Veterinary Infectious Diseases Therapeutics Market Dynamics
8.1 Veterinary Infectious Diseases Therapeutics Industry Trends
8.2 Veterinary Infectious Diseases Therapeutics Market Drivers
8.3 Veterinary Infectious Diseases Therapeutics Market Challenges
8.4 Veterinary Infectious Diseases Therapeutics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
